Patient Out of pocket analysis
Maximize revenue and improve patient access to your product
- Out of Pocket Analysis
- Financial Assistance Projects
- Expected Investment Modeling
To ensure that your product will succeed on the market, it’s imperative you have a thorough understanding of out of pocket (OOP) costs and the reimbursement support options available. While part of this is about properly communicating the value of your product, OOP costs can still be too high for certain patients.
If that is the case, there are a number of support options that might be beneficial for your product.
How We Can Help
At Two Labs, when we complete an OOP Cost Analysis, we seek to answer a number of key questions:
- What is the expected per-patient OOP cost in each channel (commercial and federal)?
- What percentage of patients will seek financial assistance in the commercial and Medicare channel (i.e. 501(c)(3))?
- What is the expected investment from a copay/financial assistance program for the commercial channel?
- What is the difference in investment between reimbursement programs?
Once we get answers, we can begin modeling different reimbursement strategies to find the optimal strategy for your drug, both in terms of market access and revenue.